233 related articles for article (PubMed ID: 23407878)
1. Non-Invasive Detection of Esophageal Cancer using Genetic Changes in Circulating Cell-Free DNA.
Ghorbian S; Ardekani AM
Avicenna J Med Biotechnol; 2012 Jan; 4(1):3-13. PubMed ID: 23407878
[TBL] [Abstract][Full Text] [Related]
2. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
3. Identifying the Common Cell-Free DNA Biomarkers across Seven Major Cancer Types.
Luo M; Liu Y; Zhao M
Biology (Basel); 2023 Jun; 12(7):. PubMed ID: 37508365
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
[TBL] [Abstract][Full Text] [Related]
5. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
Thierry AR
Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
Cervena K; Vodicka P; Vymetalkova V
Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
[TBL] [Abstract][Full Text] [Related]
7. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
[TBL] [Abstract][Full Text] [Related]
8. Circulating free tumor DNA and colorectal cancer.
Lecomte T; Ceze N; Dorval E; Laurent-Puig P
Gastroenterol Clin Biol; 2010 Dec; 34(12):662-81. PubMed ID: 20832215
[TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
Ai B; Liu H; Huang Y; Peng P
Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible?
Yuan Z; Wang X; Geng X; Li Y; Mu J; Tan F; Xue Q; Gao S; He J
Cancer Commun (Lond); 2021 Jan; 41(1):3-15. PubMed ID: 33264481
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer.
He X; Chi Y; Peng J; Hu W; Ding C; Li B
J Thorac Dis; 2022 Jun; 14(6):2103-2111. PubMed ID: 35813759
[TBL] [Abstract][Full Text] [Related]
12. Utility of Circulating Cell-Free DNA in Assessing Microsatellite Instability and Loss of Heterozygosity in Breast Cancer Using Human Identification Approach.
Al Sharhan NA; Messaoudi SA; Babu SR; Chaudhary AB; Alsharm AA; Alrefaei AF; Kadasah S; Abu-Elmagd M; Assidi M; Buhmeida A; Carracedo Á; Almawi WY
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456396
[TBL] [Abstract][Full Text] [Related]
13. Circulating Cell-free DNA in Serum as a Marker for the Early Detection of Tumor Recurrence in Breast Cancer Patients.
Bera A; Russ E; Karaian J; Landa A; Radhakrishnan S; Subramanian M; Hueman M; Pollard HB; Hu H; Shriver CD; Srivastava M
Cancer Diagn Progn; 2022; 2(3):285-292. PubMed ID: 35530653
[TBL] [Abstract][Full Text] [Related]
14.
Garzón M; Villatoro S; Teixidó C; Mayo C; Martínez A; de Los Llanos Gil M; Viteri S; Morales-Espinosa D; Rosell R
Transl Lung Cancer Res; 2016 Oct; 5(5):511-516. PubMed ID: 27826532
[TBL] [Abstract][Full Text] [Related]
15. Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus.
Rumiato E; Boldrin E; Malacrida S; Realdon S; Fassan M; Morbin T; Battaglia G; Amadori A; Rugge M; Saggioro D
Transl Res; 2017 Dec; 190():16-24.e1. PubMed ID: 29066320
[TBL] [Abstract][Full Text] [Related]
16. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance.
Gormally E; Caboux E; Vineis P; Hainaut P
Mutat Res; 2007; 635(2-3):105-117. PubMed ID: 17257890
[TBL] [Abstract][Full Text] [Related]
17. Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis.
Koba H; Kimura H; Yoneda T; Sone T; Ohkura N; Hara J; Hosomichi K; Tajima A; Kasahara K
Sci Rep; 2021 Apr; 11(1):8398. PubMed ID: 33863951
[TBL] [Abstract][Full Text] [Related]
18. Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature.
Guo XM; Miller H; Matsuo K; Roman LD; Salhia B
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671298
[TBL] [Abstract][Full Text] [Related]
19. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
[TBL] [Abstract][Full Text] [Related]
20. Identification of Somatic Mutations in Thirty-year-old Serum Cell-free DNA From Patients With Breast Cancer: A Feasibility Study.
Ritter M; Paradiso V; Widmer P; Garofoli A; Quagliata L; Eppenberger-Castori S; Soysal SD; Muenst S; Ng CKY; Piscuoglio S; Weber W; Weber WP
Clin Breast Cancer; 2020 Oct; 20(5):413-421.e1. PubMed ID: 32650988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
